共 50 条
- [31] Capecitabine Alone or in Combination in Metastatic Breast Cancer - a Single-Institution ExperienceEUROPEAN JOURNAL OF CANCER, 2011, 47 : S347 - S347Arcana, C.Ingemi, M. C.Smiroldo, V.Berenato, F.Spadaro, P.
- [32] Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Tarantino, PaoloLee, DoFoldi, JuliaSoulos, Pamela R.Gross, Cary PhilipGrinda, ThomasWiner, Eric P.Lin, Nancy U.Krop, Ian E.Tolaney, Sara M.Lustberg, Maryam B.Sammons, Sarah L.
- [33] Real-world efficacy and safety of trastuzumab deruxtecan in heavily pre-treated HER2-low metastatic breast cancer with distinct IHC statuses: Evidence from a Chinese populationANNALS OF ONCOLOGY, 2024, 35 : S1424 - S1424Wu, S.Li, J. B.Bian, L.Zhang, S.Zhang, S.Wang, T.Jiang, Z.
- [34] Real-World Vinflunine Outcomes in Bladder Cancer in a Single-Institution Study: Moving Beyond Clinical TrialsCLINICAL GENITOURINARY CANCER, 2015, 13 (06) : 588 - 592Moriceau, GuillaumeVallard, AlexisRivoirard, RomainMery, BenoiteEspenel, SophieLangrand-Escure, JulienBen Mrad, MajedWang, GuopingDiao, PengPacaut, CecileGuillot, AlineCollard, OlivierFournel, PierreMagne, Nicolas
- [35] PREVALENCE OF GENETIC TESTING AND MUTATIONS IN METASTATIC PROSTATE CANCER IN REAL-WORLD PRACTICE AT A SINGLE INSTITUTIONJOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 673 - 674Blake, Z.Maslov, D.Burton, J.Gadde, S.Markabawi, D.Khan, A.Righi, S.Esmaeili, A.Catalfamo, V.Long, W.Matrana, M.Johnson, D.Tawagi, K.
- [36] A meta-analysis analyzing the efficacy of trastuzumab-deruxtecan (T-DXd) on central nervous system (CNS) disease in patients with metastatic breast cancer (mBC)JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Kumar, Prashanth AshokSandhu, MichaelSravanthi, Metlapalli VenkataDesai, DevashishKumar, Vishnu Charan SureshBenjamin, Sam
- [37] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancerONCOLOGY LETTERS, 2025, 29 (01)Qian, XiaoyanTao, YunxiaChen, HaizhuLi, XinWang, YaqinXu, XiaomingLi, ShuoChen, HaoyuCang, ShundongLiu, Yang
- [38] Use and Outcomes of Trastuzumab Deruxtecan in HER2-positive and HER2-low Metastatic Breast Cancer in Real-World Setting: A Nationwide Cohort StudyPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 531 - 531Jourdain, HugoDesplas, DavidMansouri, ImeneZureik, MahmoudDi Meglio, AntonioHaddy, Nadia
- [39] Real-world experience with trastuzumab deruxtecan in patients with breast cancer: 6 month-interim analysis of an all-patient postmarketing surveillance in JapanCANCER RESEARCH, 2024, 84 (09)Tsurutani, JunjiMizutani, HidekiTanabe, Ayumi
- [40] Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab DeruxtecanNPJ PRECISION ONCOLOGY, 2025, 9 (01)Fabi, AlessandraRossi, AlessandroCaputo, RobertaPisegna, SimonaScagnoli, SimonePantano, FrancescoD'Auria, GiulianaFedele, PalmaFabbri, AgneseVernieri, ClaudioPalleschi, MichelaCarbognin, LuisaFerretti, GianluigiDi Monte, ElenaParis, IdaPavese, FrancescoGarrone, OrnellaFranco, AntonioDe Laurentiis, MichelinoFranceschini, GianlucaScambia, GiovanniGiannarelli, DianaMasetti, RiccardoBotticelli, Andrea